enGene Therapeutics Inc. Warrants (ENGNW) Live Share Price, Invest From India

enGene Therapeutics Inc. Warrants Stock Performance

as on October 24, 2026 at 5:55 am IST

Day's Low
Day's High
$0.20
Day's Price Range
$0.24
$0.23
13.01%
Downside
4.39%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.23
100.00%
Downside
-100.00%
Upside

enGene Therapeutics Inc. Warrants share price movements today

Previous Close: $0.19
Open: $0.21
Volume: 40.1K
Day's Low - High: $0.20 - $0.24

enGene Therapeutics Inc. Warrants Historical Returns

1 Month Return: -44.15 %
3 Month Return: -47.25 %
1 Year Return: -91.33 %
3 Year Return: 0 %
5 Year Return: 0 %

enGene Therapeutics Inc. Warrants Stock Fundamentals & Key Indicators

Check enGene Therapeutics Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

-60.50%

enGene Therapeutics Inc. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of enGene Therapeutics Inc. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
enGene Therapeutics Inc. Warrants	NA	$-	NA	NA	0.00%	0.00%

Stock Returns calculator for enGene Therapeutics Inc. Warrants Stock including INR - Dollar returns

The enGene Therapeutics Inc. Warrants stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

enGene Therapeutics Inc. Warrants investment value today

Current value as on today

₹11,354

Returns

-₹88,646

(-88.65%)

Returns from enGene Therapeutics Inc. Warrants Stock

-₹89,502 (-89.5%)

Dollar Impact

₹856 (+0.86%)

Indian Investors' Interest in enGene Therapeutics Inc. Warrants Stock

Search interest for enGene Therapeutics Inc. Warrants Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:-45% versus previous 30 day period

enGene Therapeutics Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Total Revenue	-	-	0	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-17	-16	-17	-26	-27	-29	-39	-31	31	34
EBITDA	-14	-13	-14	-23	-24	-27	-37	-28	-31	-33
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-14	-15	-24	-25	-28	-38	-29	30	32
Income Tax Expense	0	0	0	0	0	0	0	-	-	-
Net Income	-14	-14	-15	-24	-25	-28	-37	-29	30	32
Net Profit Margin	0.00%	0.00%	-3187.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

enGene Therapeutics Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

	Oct 2020	Oct 2021	Oct 2022	Oct 2023	Oct 2024	Oct 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0
Operating Income	-13	-15	-19	-26	-62	-123
EBITDA	-12	-18	-22	-94	-52	-113
Interest Expense	3	5	1	4	2	2
Depreciation	0	0	0	0	0	0
Income Before Tax	-15	-23	-24	-99	-55	-117
Income Tax Expense	4	4	0	0	0	-
Net Income	-15	-23	-24	-99	-55	-117
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

enGene Therapeutics Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Net Income	-14	-15	-24	-25	-28	-37	-29	-30	-32
Operating Cash Flow	-7	-19	-25	-22	-25	-24	-28	-30	-18
Investing Cash Flow	0	-125	-84	17	1	40	-126	23	30
Financing Cash Flow	0	60	0	0	0	1	141	0	0
Change in Cash	-7	-84	-110	-4	-24	17	-13	-6	11

enGene Therapeutics Inc. Warrants Annual Cash Flow

All numbers in Millions USD

	Oct 2021	Oct 2022	Oct 2023	Oct 2024	Oct 2025
Net Income	-23	-24	-99	-55	-117
Operating Cash Flow	-15	-17	-24	-48	-99
Investing Cash Flow	0	0	0	-125	-25
Financing Cash Flow	22	27	86	265	1
Change in Cash	6	9	61	91	-122

About enGene Therapeutics Inc. Warrants

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.

Organisation	enGene Therapeutics Inc. Warrants
Headquarters	4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
Industry	Health Care
CEO	Mr. Ronald H. W. Cooper

Key Management of enGene Therapeutics Inc. Warrants

Name	Title
Mr. Matthew Boyd	Chief Regulatory Officer
Ms. Amy Pott	Chief Global Commercialization Officer
Mr. Ronald H. W. Cooper	President, CEO & Director
Dr. William J. Grossman M.D., Ph.D.	Interim Chief Medical Officer & Director
Ms. Tara Place M.B.A.	Senior VP of Human Resources
Ms. Jill Buck	Chief Development Officer
Ms. Kathleen Richton	Senior VP of Finance, Principal Accounting & Financial Officer and Controller
Ms. Joan Connolly	Chief Technology Officer
Dr. Anthony T. Cheung Ph.D.	Consultant

FAQs

What is enGene Therapeutics Inc. Warrants share price today?

enGene Therapeutics Inc. Warrants share price today is $0.23 as on October 24, 2026 at 12:25 am IST. enGene Therapeutics Inc. Warrants share today touched a day high of $0.24 and a low of $0.20.

What is the 52 week high and 52 week low for enGene Therapeutics Inc. Warrants share?

enGene Therapeutics Inc. Warrants share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. enGene Therapeutics Inc. Warrants stock price today i.e. October 24, 2026 at 12:25 am IST is trending at $0.23,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in enGene Therapeutics Inc. Warrants Stock (ENGNW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for enGene Therapeutics Inc. Warrants on INDmoney app. Click on Buy button.

What is the minimum amount required to buy enGene Therapeutics Inc. Warrants Stock (ENGNW) from India?

Indian investors can start investing in enGene Therapeutics Inc. Warrants (ENGNW) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 12:55 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in enGene Therapeutics Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 12:55 am IST). Based on enGene Therapeutics Inc. Warrants share’s latest price of $0.23 as on October 24, 2026 at 12:25 am IST, you will get 43.4972 shares of enGene Therapeutics Inc. Warrants. Learn more about fractional shares .